Skip to main content
# Title Department Research Member Research Year
21 Diagnostic efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions Department of Radiology Dr. Doaa Mohamed Fouad Mahmoud 2024
22 Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study Department of Radiotherapy and Nuclear medicine Dr. Esraa Roshdy Hassan Mohamed 2024
23 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2024
24 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Department of Medical Oncology Amany Nasr Ahmed Mohammed Elemary 2023
25 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
26 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Amany Mohammed Abdel Moatamed 2023
27 18F-FDG gallbladder uptake: observation from a total-body PET/CT scanner Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2023
28 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Prof. Hesham Mahmoud Mohamed Mahmoud 2023
29 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023
30 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023